150 related articles for article (PubMed ID: 12090563)
41. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
42. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
To CH; Petri M
Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
[TBL] [Abstract][Full Text] [Related]
43. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
[TBL] [Abstract][Full Text] [Related]
44. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
[TBL] [Abstract][Full Text] [Related]
45. Systemic lupus erythematosus in the Fars Province of Iran.
Nazarinia MA; Ghaffarpasand F; Shamsdin A; Karimi AA; Abbasi N; Amiri A
Lupus; 2008 Mar; 17(3):221-7. PubMed ID: 18372364
[TBL] [Abstract][Full Text] [Related]
46. The Jo-1 antibody system in myositis: relationships to clinical features and HLA.
Arnett FC; Hirsch TJ; Bias WB; Nishikai M; Reichlin M
J Rheumatol; 1981; 8(6):925-30. PubMed ID: 6977032
[TBL] [Abstract][Full Text] [Related]
47. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
48. IgA deficiency and SLE: prevalence in a clinic population and a review of the literature.
Rankin EC; Isenberg DA
Lupus; 1997; 6(4):390-4. PubMed ID: 9175025
[TBL] [Abstract][Full Text] [Related]
49. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
50. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
[TBL] [Abstract][Full Text] [Related]
51. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
52. ANA negative (Ro) lupus erythematosus with multiple major organ involvement: a case report.
Maraina CH; Kamaliah MD; Ishak M
Asian Pac J Allergy Immunol; 2002 Dec; 20(4):279-82. PubMed ID: 12744629
[TBL] [Abstract][Full Text] [Related]
53. Clinical and laboratory features of patients of Vietnamese descent with systemic lupus erythematosus.
Phan JC; Bush TM; Donald F; Ward M
Lupus; 1999; 8(7):521-4. PubMed ID: 10483029
[TBL] [Abstract][Full Text] [Related]
54. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.
Zheng WJ; Tian XP; Li L; Jing HL; Li F; Zeng XF; Tang FL
J Clin Rheumatol; 2007 Dec; 13(6):313-6. PubMed ID: 18176138
[TBL] [Abstract][Full Text] [Related]
55. Rare autoantibodies to cellular antigens in systemic lupus erythematosus.
Fredi M; Cavazzana I; Quinzanini M; Taraborelli M; Cartella S; Tincani A; Franceschini F
Lupus; 2014 Jun; 23(7):672-7. PubMed ID: 24557777
[TBL] [Abstract][Full Text] [Related]
56. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.
Amezcua-Guerra LM; Springall R; Marquez-Velasco R; Gómez-García L; Vargas A; Bojalil R
Arthritis Res Ther; 2006; 8(5):R144. PubMed ID: 16934155
[TBL] [Abstract][Full Text] [Related]
57. Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram's PR interval in adult patients with systemic lupus erythematosus.
Costa M; Gameiro Silva MB; Silva JA; Skare TL
Acta Reumatol Port; 2008; 33(2):173-6. PubMed ID: 18604183
[TBL] [Abstract][Full Text] [Related]
58. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[TBL] [Abstract][Full Text] [Related]
59. Avascular necrosis of bone in systemic lupus erythematosus. The predictive role of precipitating autoantibodies.
Watanabe T; Tsuchida T; Kanda N; Tamaki K
Scand J Rheumatol; 1997; 26(3):184-7. PubMed ID: 9225873
[TBL] [Abstract][Full Text] [Related]
60. Orbital inflammation, myositis, and systemic lupus erythematosus.
Grimson BS; Simons KB
Arch Ophthalmol; 1983 May; 101(5):736-8. PubMed ID: 6847461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
